文献速递运动医学关节外科

上关节囊重建术后移植物撕裂但肱骨大结节仍被覆盖的患者与移植物完整患者功能结局相似

Patients With Graft Tears Leaving the Tuberosity Covered Have Similar Functional Outcomes to Those With an Intact Graft After Superior Capsular Reconstruction.
PubMed 文献 · Am J Sports Med · 2024-01-01

单中心队列研究纳入39例采用脱细胞真皮异体移植行上关节囊重建的患者,术后MRI评估移植物完整性并按撕裂位置分组。移植物完整组与撕裂但大结节仍被覆盖组术后ASES、Oxford、VAS、SANE评分无显著差异,而大结节裸露组功能结局显著更差。

要点

  • 上关节囊重建术后移植物撕裂但大结节仍被覆盖者,功能结局与移植物完整者相当。
  • 大结节裸露的移植物撕裂或溶解者术后功能结局显著更差。
  • 术后MRI评估移植物撕裂位置对判断预后有重要意义。

核心结论

  • 采用真皮异体移植行上关节囊重建后发生移植物撕裂但大结节仍被覆盖的患者,其功能结局与移植物完整者相当。

研究设计与样本

  • 队列研究,证据等级3;纳入单中心接受脱细胞真皮异体移植行上关节囊重建的患者39例,平均年龄60.4±8.7岁,平均随访53.3±25个月(范围14-98个月)。

主要发现

  • 术后MRI于平均17.5个月(范围6-66个月)评估:移植物完整14例(36%),盂侧撕裂11例(28%),中段撕裂4例(10%),大结节侧撕裂8例(21%),移植物完全消失2例(5%)。
  • 1组(移植物完整)ASES从37.9改善至88.5(P<.001),Oxford从25.2改善至46.2(P<.001),VAS从6.8改善至0.9(P<.001)。
  • 2组(大结节被覆盖:盂侧及中段撕裂)ASES从32.2改善至86.1(P<.001),Oxford从23.4改善至44.2(P<.001),VAS从7.3改善至1.3(P<.001)。
  • 3组(大结节裸露:大结节侧撕裂及移植物溶解或消失)ASES从40.3至45.8无显著改善(P=.50),Oxford从33.5至31.4无显著改善(P=.81),VAS从7.1至5.4显著降低(P=.03)。
  • 1组与2组术后ASES(88.5 vs 86.1,P=.59)、Oxford(46.2 vs 44.2,P=.07)、VAS(0.9 vs 1.3,P=.42)、SANE(85.4 vs 83.2,P=.92)均无显著差异;3组术后ASES(45.8,P<.001)、Oxford(31.4,P<.001)、SANE(45.4,P<.001)显著低于1组和2组,VAS(5.4,P<.001)显著高于1组和2组。

关键数值与推荐

  • 移植物完整组术后ASES 88.5、Oxford 46.2、VAS 0.9、SANE 85.4。
  • 大结节被覆盖组术后ASES 86.1、Oxford 44.2、VAS 1.3、SANE 83.2。
  • 大结节裸露组术后ASES 45.8、Oxford 31.4、VAS 5.4、SANE 45.4。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies to date of superior capsular reconstruction (SCR) comparing outcomes of healed grafts versus torn grafts do not separate graft tears based on location of the tear, rather they combine and report all tears as a single group. PURPOSE/HYPOTHESIS: The purpose of this study was to correlate functional outcome with graft integrity and graft tear location after SCR with a dermal allograft. It was hypothesized that the functional outcomes of patients with an intact graft would be equivalent to those with graft tears leaving the tuberosity covered. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients who underwent SCR with an acellular dermal allograft at a single institution were included. Pre- and postoperative American Shoulder and Elbow Surgeons (ASES), Oxford Shoulder Score, visual analog scale (VAS) for pain, and postoperative Single Assessment Numeric Evaluation (SANE) scores were recorded. A magnetic resonance imaging scan was performed postoperatively to assess graft integrity. RESULTS: A total of 39 patients met inclusion criteria. Mean age of patients was 60.4 ± 8.7 years; mean follow-up was 53.3 ± 25 months (range, 14-98 months). Magnetic resonance imaging performed at a mean of 17.5 months (range, 6-66 months) demonstrated an intact graft in 14 (36%); tear from the glenoid in 11 (28%), from midsubstance in 4 (10%), and from the tuberosity in 8 (21%); and complete graft absence in 2 (5%). Patients were divided into group 1 (intact graft), group 2 (tuberosity covered: tears from glenoid and midsubstance tears), and group 3 (tuberosity bare: tears from the tuberosity and dissolved or absent grafts). In group 1, there was significant improvement in ASES (37.9 to 88.5; P < .001), Oxford (25.2 to 46.2; P < .001), and VAS (6.8 to 0.9; P < .001). In group 2, there was significant improvement in ASES (32.2 to 86.1; P < .001), Oxford (23.4 to 44.2; P < .001), and VAS (7.3 to 1.3; P < .001). In group 3, there was no significant improvement in ASES (40.3 to 45.8; P = .50) or Oxford (33.5 to 31.4; P = .81), but there was a significant reduction in VAS (7.1 to 5.4; P = .03). There was no significant difference between group 1 and 2 in postoperative ASES (88.5 vs 86.1; P = .59), Oxford (46.2 vs 44.2; P = .07), VAS (0.9 vs 1.3, P = .42) and SANE (85.4 vs 83.2; P = .92) scores. However, group 3 had significantly lower ASES (45.8; P < .001), lower Oxford (31.4; P < .001), lower SANE (45.4; P < .001), and higher VAS (5.4; P < .001) scores than groups 1 and 2. There were no differences in outcomes based on sex (P = .72), previous surgery (P = .06), preoperative acromiohumeral distance (P = .57), and preoperative Goutallier stage of the supraspinatus (P = .16). CONCLUSION: Patients who underwent SCR with a dermal allograft and developed a graft tear leaving the tuberosity covered had equivalent functional outcomes to those with an intact graft.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Mirzayan R, Acevedo DC, Yao JF, et al. Patients With Graft Tears Leaving the Tuberosity Covered Have Similar Functional Outcomes to Those With an Intact Graft After Superior Capsular Reconstruction. Am J Sports Med. 2024. PMID: 39432391. doi:10.1177/03635465241278358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。